Buckingham Cuts Hospira (HSP) to Neutral
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
An analyst at Buckingham Research downgraded shares of Hospira (NYSE: HSP) from Buy to Neutral in an intraday research note.
The lowered investment rating follows a reduced outlook from Hospira this morning. The stock is down more than 20 percent Tuesday afternoon.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
The lowered investment rating follows a reduced outlook from Hospira this morning. The stock is down more than 20 percent Tuesday afternoon.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Create E-mail Alert Related Categories
DowngradesRelated Entities
Buckingham ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
